"The mechanism of action of CCH-aaes for cellulite-related contour alterations in women is enzymatic disruption of the fibrous septae, to create a skin-smoothing effect. A different formulation of CCH is indicated in the United States for the treatment of other collagen-associated disorders, Dupuytren’s contracture, and Peyronie's disease."